Triggering of large granular lymphocyte (LGL) Fc receptor with a specific monoclonal antibody (AB8.28) linked to an insoluble matrix induces cell activation, as witnessed by expression of HLA class II (DR and DQ) molecules and interleukin 2 receptor. Moreover, this event is accompanied by a concomitant release of platelet-acivating factor by LGL. We conclude that the Fc receptor molecule identified by mAb AB8.28 represents a trigger for LGL activation.
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Large granular lymphocytes (LGL) constitute a discrete population of peripheral blood mononuclear cells that perform several functions, among which natural killing is the best known. Recent evidence (1) suggests that only a part of the entire cellular potential of LGL is known and other novel regulatory and functional properties may be attributed to them. The study ofLGL using monoclonal antibodies (mAbs) has made it possible to define a gross map of the cell surface that includes structures expressed by the majority of cells displaying LGL features and others, such as Leu7, C3b receptor, or N901 (2) , that are present on variable proportions of the population. A general observation is that many markers present on LGL are also expressed by cells belonging to other lineages; furthermore, most of these markers are located on molecules whose functions are unknown. A relevant exception is the molecule recognized by mAbs AB8. 28 (3) , Leull, B73.1, 3G8, and VEP13, which appear to identify an Fc receptor (FcR) for human IgG (4) . These reagents also react with the FcR of polymorphonuclear neutrophils (PMN), but they do not recognize the FcR of B lymphocytes and monocytes (4) , which supports the view that FcR are a family of multiple molecules. The aims of this study were 2-fold: (i) to investigate if the FcR identified by mAb AB8.28 could function as a molecule switch for cell activation and (ii) to identify the main events occurring in LGL after antibody triggering. We present evidence that the stimulation of LGL FcR with mAb AB8.28 covalently bound to an insoluble matrix (Sepharose CL-4B) induces LGL activation and expression of HLA class II (DR and DQ) and interleukin 2 (IL-2) receptor (TAC) antigens. Simultaneously, we observed that LGL release platelet-activating factor (PAF), a powerful mediator ofcell-cell interaction (5) with an in vitro toxic effect on cultured normal and neoplastic cells (6) . These data may provide a clue toward understanding the initial steps in activation of the natural killer (NK) cell activity in vivo.
MATERIALS AND METHODS
mAbs. mAb AB8.28 was obtained with peripheral blood lymphocytes (PBL) of a healthy blood donor as the immunogen (3) . Other mAbs used for phenotypic studies were R1.30 (anti-B2-microglobulin), 01.65 (anti-HLA class I), A10 and BT3/4 (anti-HLA DQ1) (Technogenetics, S. Mauro T., Italy), AA3.84 (anti-HLA DR) (7), Tu22 (anti-HLA DQ) (8), Leul, Leu7, Leull, and anti-TAC (Becton Dickinson), CB01 (anti-T cells and thymocytes) (unpublished), CB12 (anti-monocytes) (9) , and Mol and B1 (Coulter).
Preparation of Cells. PBL of healthy donors were isolated from heparinized blood by density-gradient centrifugation using Ficoll/Hypaque (Pharmacia), depleted of plastic-adherent monocytes, and resuspended in RPMI 1640 medium. The percentage of macrophages/monocytes never exceeded 2% (10) . T cells, PMN, and monocytes were prepared as described (11) . In a limited number of experiments, an AB8.28+ subset was purified by negative selection by depletion with immunorosette and anti-pan T, anti-monocytes, anti-HLA class II, and anti-Bi along with removal of plasticadherent cells.
Immunorosetting. Ox erythrocytes were coupled to protein A in the presence of0.01% CrCl3 using the procedure of Ling et al. (12) (14) and incubated with calcium ionophore A23187 (Boehringer Mannheim, 2 ,ug/ml) and 50, 10, and 1 Al of AB8.28-Sepharose, 01.65-Sepharose, and AA3.84-Sepharose, respectively. In some experiments, acetyl-coenzyme A (Ac-CoA, 0.2 mM) was added to the cells. The cell-free supernatants were extracted in methanol, and the lipid material was phased into chloroform (15) and purified as described below. As controls, 1 x 106 PMN and 1 x 106 monocytes were challenged with A23187 (2 Lg/ml) and AB8.28-Sepharose (50, 10, 1 ,ul). The cell supernatants were then processed as above. PAF was detected by aggregation of rabbit platelets (2-5 x 107) in Tris/Tyrode buffer containing 0.25% gelatin in the presence of indomethacin and the creatine phosphate/creatine phosphokinase enzymatic system. The amount of PAF was quantitated and expressed as described (14) .
Purification and Characterization ofPAF. PAF was purified by TLC (15) . The lipid material with a retention front (Rf = 0.21) identical to that of synthetic 1-0-octadecyl-2-acetyl-snglycero-3-phosphocholine (Bachem, Bubendorf, Switzerland) (PAF) was further characterized by its retention time on a HPLC apparatus (Beckman). Elution was carried out on a linear gradient over 15 min (16) and the fractions were bioassayed on rabbit platelets. Identity between HPLCeluted material and synthetic 1-0-octadecyl-2-acetyl-snglycero-3-phosphocholine was established on the basis of similar physical and chemical characteristics and sensitivity to lipases (17) . (Table 2) . To test the specificity of the effect observed, the same preparations were challenged with insolubilized AB8.28 mAb. PMN could also be triggered (though to a much lower extent), in contrast to monocytes, which were totally unresponsive. However, no PAF was released from LGL challenged with Sepharose beads coated with mAb 01.65 or AA3.84. The release of PAF from LGL was maximal 45 min after challenge with mAb AB8.28-Sepharose (Fig. LA) and A23187 (Fig. 1B) . In quantitative terms, PAF release obtained from 2 x 106 LGL after challenge with A23187 was comparable to that obtained from 1 x 106 PMN ( Table 2 ). As shown in Fig. 2 , at least 1 x 106
RESULTS
LGL were necessary to observe detectable amounts of PAF after challenge with A23187 and AB8. receptor, the antibody anti-FcR covalently bound to an insoluble matrix (Sepharose CL-4B) was able to induce LGL to express surface "activation" markers and to concomitantly release PAF in the culture supernatant. After incubation with AB8.28-Sepharose, the majority of LGL cells expressed either monomorphic DR or DQ determinants, along with TAC, thus demonstrating by multiple phenotypic criteria that they were in an activated state. Next, we focused our attention on the release by AB8.28-activated LGL of the soluble mediator PAF. The appearance of human Ia paralleled the release of a significant amount of PAF. The latter event was further confirmed by treating resting LGL with A23187, a stimulus that bypasses the receptor and activates a specific acetyltransferase necessary for PAF biosynthesis (20) . Maximal PAF release occurred 45 min after challenge with AB8.28-Sepharose and A23187. PAF released by A23187-treated LGL was almost half the amount obtained from an analogous concentration of PMN, even if this may be an underestimate, since the long purification might reduce LGL potential for PAF biosynthesis. The lipid material released from LGL shared with synthetic 1-0-octadecyl-2-acetyl-sn-glycero-3-phosphocholine the physical and chemical characteristics (21) , the retention time on HPLC, the sensitivity to phospholipase A2 (17) , and biological activity on rabbit platelets (22) . The enhancement of PAF release in the presence of Ac-CoA suggested an acetylation process in the PAF biosynthesis (14) . The (27) and are probably due to expansion of a residual small PBL subset, a vestigium of a population active during fetal life: in fact, mononuclear cells from fetal (16 week) thymus are AB8.28+ (28) .
(it) LGL are a potent source of mediators such as interleukin 1 (29) , leukotrienes (30), NK cytotoxic factor (31) , and-as demonstrated here-PAF. All of these factors could play a significant role in the NK toxic mechanism(s) or in cell-cell interactions (5), as suggested by Hoffman et al. (6) , who showed that PAF and its analogues (in high concentrations) are cytotoxic for human cultured cells. Furthermore, LTB4, an activator of other cell systems such as PMN, may lead to the release ofpostulated cytotoxic factors (32) such as PAF.
(iii) The expression of class II antigens may prompt revision of the view that NK function is fully HLA-independent. A working hypothesis is that activation by way of FcR is a physiological event that induces human Ia expression during cell-cell interactions. The inability to detect expression ofclass II antigens in all LGL may reflect the inadequacy of the stimulus or of the experimental conditions. In keeping with this possibility is the observation that soluble mAbs are unable to trigger LGL. This may be due to the extremely brief duration of the triggering event(s) mediated by soluble antibody, which cannot be recorded.
To our knowledge, it has not been reported previously that LGL induction upon FcR triggering is allowed by LGL activation and expression of DR/DQ molecules and IL-2 receptor on the cell surface along with the release of PAF, a mediator of cell-cell communication. Proc. Natl. Acad Sci. USA 83 (1986) 
